← Open Payments lookup

SIMONE FAYBYSHEV: Open Payments

NPI 1861056178 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$342 in 14 payments from 7 companies in 2025. Trend: 2023 $1,003 · 2024 $1,068 · 2025 $342

Food & beverage: $342
CompanyPaymentsAmount
Gilead Sciences, Inc.5$121
Bayer Healthcare Pharmaceuticals Inc.2$61
Lilly USA, LLC2$45
AstraZeneca Pharmaceuticals LP2$40
Astellas Pharma US Inc1$30
GlaxoSmithKline, LLC.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19

Products named: Kerendia, MOUNJARO, Veozah, TRELEGY ELLIPTA, AIRSUPRA, XIFAXAN, FARXIGA.

Industry payments across NY — which companies pay providers there.